Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA12 | O43570 | 11/20 | 0.47 |
| ▸ | CA1 | P00915 | 11/20 | 0.47 |
| ▸ | CA2 | P00918 | 11/20 | 0.47 |
| ▸ | CA9 | Q16790 | 11/20 | 0.47 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.47 |
| ▸ | PTGS2 | P35354 | 3/20 | 0.44 |
| ▸ | PTGS1 | P23219 | 2/20 | 0.44 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.43 |
| ▸ | LMNA | P02545 | 1/20 | 0.43 |
| ▸ | TP53 | P04637 | 1/20 | 0.43 |
| ▸ | MAPK14 | Q16539 | 1/20 | 0.43 |
| ▸ | CCNC | P24863 | 1/20 | 0.42 |
| ▸ | CDK8 | P49336 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL8181108 | 1.00 | CA12 (0.47) | CA12CA1CA2CA9CA14 | |
| SCHEMBL8180608 | 0.90 | LMNA (0.44) | PTGS2PTGS1LMNATP53MAPK14 | |
| SCHEMBL8174966 | 0.90 | LMNA (0.44) | PTGS2PTGS1LMNATP53MAPK14 | |
| SCHEMBL8175722 | 0.88 | TP53 (0.46) | CA12CA1CA2CA9PTGS2 | |
| SCHEMBL7797261 | 0.88 | CA9 (0.50) | CA12CA1CA2CA9PTGS2 | |
| SCHEMBL8174276 | 0.88 | TP53 (0.46) | CA12CA1CA2CA9PTGS2 | |
| SCHEMBL8168023 | 0.88 | CA9 (0.50) | CA12CA1CA2CA9PTGS2 | |
| SCHEMBL7773121 | 0.87 | MAPK14 (0.45) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7773321 | 0.87 | IKBKB (0.46) | CA12CA1CA2CA9CA14 | |
| SCHEMBL7779465 | 0.87 | MAPK14 (0.45) | CA12CA1CA2CA9CA14 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0772597-B1 | 3,4-SUBSTITUTED PYRAZOLES FOR THE TREATMENT OF INFLAMMATION | SEARLE & CO (US) | 2001-12-12 | — | — | EP | claimed |
| US-6028072-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | claimed |
| US-6028072-A | 3,4-substituted pyrazoles for the treatment of inflammation | G. D. SEARLE & CO. (US) | 2000-02-22 | — | — | US | disclosed |